|
2023 Journal Article Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: design and implementation of a randomised controlled trialHayes, Sandra, Obermair, Andreas, Mileshkin, Linda, Davis, Alison, Gordon, Louisa G., Eakin, Elizabeth, Janda, Monika, Beesley, Vanessa L., Barnes, Elizabeth H., Spence, Rosalind Renee, Sandler, Carolina, Jones, Tamara, Vagenas, Dimitrios, Webb, Penny, Andrews, John, Brand, Alison, Lee, Yeh Chen, Friedlander, Michael, Pumpa, Kate, O’Neille, Helene, Williams, Merran, Stockler, Martin and The ECHO Collaborative (2023). Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: design and implementation of a randomised controlled trial. BMJ Open, 13 (4) e067925, e067925. doi: 10.1136/bmjopen-2022-067925 |
|
2023 Journal Article The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: a call for researchViolette, Caroline J., Agarwal, Ravi, Mandelbaum, Rachel S., González, José L., Hong, Kurt M., Roman, Lynda D., Klar, Maximilan, Wright, Jason D., Paulson, Richard J., Obermair, Andreas and Matsuo, Koji (2023). The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: a call for research. Expert Review of Anticancer Therapy, 23 (4), 1-11. doi: 10.1080/14737140.2023.2194636 |
|
2023 Journal Article Can simple hysterectomy replace radical hysterectomy as treatment of early-stage cervical cancer?Obermair, Andreas and Pareja, Rene (2023). Can simple hysterectomy replace radical hysterectomy as treatment of early-stage cervical cancer?. International Journal of Gynecologic Cancer, 33 (4), 647-647. doi: 10.1136/ijgc-2023-004372 |
|
2023 Journal Article Role of adjuvant therapy in intermediate-risk cervical cancer patients: subanalyses of the SCCAN studyCibula, David, Akilli, Huseyin, Jarkovsky, Jiri, van Lonkhuijzen, Luc, Scambia, Giovanni, Meydanli, Mehmet Mutlu, Ortiz, David Isla, Falconer, Henrik, Abu-Rustum, Nadeem R., Odetto, Diego, Klát, Jaroslav, dos Reis, Ricardo, Zapardiel, Ignacio, Di Martino, Giampaolo, Presl, Jiri, Laky, Rene, López, Aldo, Weinberger, Vit, Obermair, Andreas, Pareja, Rene, Poncová, Renata, Mom, Constantijne, Bizzarri, Nicolò, Borčinová, Martina, Aslan, Koray, Salcedo Hernandez, Rosa Angélica, Fons, Guus, Benešová, Klára, Dostálek, Lukáš and Ayhan, Ali (2023). Role of adjuvant therapy in intermediate-risk cervical cancer patients: subanalyses of the SCCAN study. Gynecologic Oncology, 170, 195-202. doi: 10.1016/j.ygyno.2023.01.014 |
|
2023 Journal Article Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) StudyMajidi, Azam, Na, Renhua, Jordan, Susan J., DeFazio, Anna, Obermair, Andreas, Friedlander, Michael, Grant, Peter and Webb, Penelope M (2023). Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) Study. JNCI: Journal of the National Cancer Institute, 115 (5), 570-577. doi: 10.1093/jnci/djac239 |
|
2023 Conference Publication Age is the best predictor of MLH1 promotor methylation in mismatch repair deficient endometrial carcinomaGounden, S., Obermair, A., Garrett, A., Mar Fan, H. and Cummings, M. (2023). Age is the best predictor of MLH1 promotor methylation in mismatch repair deficient endometrial carcinoma. Pathology Update 2023, Melbourne, VIC, Australia, 24-26 February 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.pathol.2022.12.182 |
|
2023 Journal Article Groin surveillance by serial ultrasonography rather than sentinel node biopsy or inguinofemoral lymphadenectomy for patients with vulvar cancer: a pilot studyHacker, Neville F., Barlow, Ellen L., McNally, Glenn, Morrell, Stephen, Gebski, Val and Obermair, Andreas (2023). Groin surveillance by serial ultrasonography rather than sentinel node biopsy or inguinofemoral lymphadenectomy for patients with vulvar cancer: a pilot study. Cancers, 15 (3) 831, 1-11. doi: 10.3390/cancers15030831 |
|
2022 Conference Publication Exercise during chemotherapy for recurrent ovarian cancer (ECHO-R): A Phase II trial evaluating feasibility, safety and efficacy of an individually-tailored exercise intervention during chemotherapy for recurrent ovarian cancerSandler, Carolina, Spence, Rosalind, Obermair, Andreas, Janda, Monika, Eakin, Elizabeth, Beesley, Vanessa, Vegenas, Domitrios, Gordon, Louisa, Webb, Penelope, Williams, Merran, O'Neill, Helene and Hayes, Sandi (2022). Exercise during chemotherapy for recurrent ovarian cancer (ECHO-R): A Phase II trial evaluating feasibility, safety and efficacy of an individually-tailored exercise intervention during chemotherapy for recurrent ovarian cancer. HOBOKEN: WILEY. |
|
2022 Journal Article Collaborative centralization of gynaecological cancer careMoloney, Kristen, Rao, Archana and Obermair, Andreas (2022). Collaborative centralization of gynaecological cancer care. Current Opinion in Oncology, 34 (5), 518-523. doi: 10.1097/CCO.0000000000000865 |
|
2022 Journal Article Vaginal vault smear cytology in detection of recurrence after hysterectomy for early cervical cancerGrace, Leah, Sanday, Karen, Garrett, Andrea, Land, Russell, Nicklin, Jim, Obermair, Andreas, Rao, Archana, Tang, Amy and Allanson, Emma R. (2022). Vaginal vault smear cytology in detection of recurrence after hysterectomy for early cervical cancer. International Journal of Gynecological Cancer, 32 (7) ijgc-2021-003302, 853-860. doi: 10.1136/ijgc-2021-003302 |
|
2022 Journal Article Toward incorporating health-related quality of life as coprimary end points in clinical trials: time to achieve clinical important differences and QoL profilesGebski, Val, Obermair, Andreas and Janda, Monika (2022). Toward incorporating health-related quality of life as coprimary end points in clinical trials: time to achieve clinical important differences and QoL profiles. Journal of Clinical Oncology, 307 (21) e2102750, 2378-2388. doi: 10.1200/jco.21.02750 |
|
2022 Journal Article Germline BRCA variants, lifestyle and ovarian cancer survivalGersekowski, Kate, Delahunty, Rachel, Alsop, Kathryn, Goode, Ellen L., Cunningham, Julie M., Winham, Stacey J., Pharoah, Paul, Song, Honglin, Jordan, Susan, Fereday, Sian, DeFazio, Anna, Friedlander, Michael, Obermair, Andreas and Webb, Penelope M. (2022). Germline BRCA variants, lifestyle and ovarian cancer survival. Gynecologic Oncology, 165 (3), 437-445. doi: 10.1016/j.ygyno.2022.03.020 |
|
2022 Journal Article Are endometrial cancer clinical practice management guidelines sufficiently consumer centric?Obermair, Andreas, McNally, Orla, Farrell, Rhonda, Ribeiro, Reitan and Ng, Joseph Soon-Yau (2022). Are endometrial cancer clinical practice management guidelines sufficiently consumer centric?. International Journal of Gynecologic Cancer, 32 (7), ijgc-2022. doi: 10.1136/ijgc-2022-003580 |
|
2022 Journal Article Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancerCohen, Paul A., Webb, Penelope M., King, Madeleine, Obermair, Andreas, Gebski, Val, Butow, Phyllis, Morton, Rachael, Lawson, Wanda, Yates, Patsy, Campbell, Rachel, Meniawy, Tarek, McMullen, Michelle, Dean, Andrew, Goh, Jeffrey, McNally, Orla, Mileshkin, Linda, Beale, Philip, Beach, Rhonda, Hill, Jane, Dixon, Cyril, Hegarty, Sue, Codde, Jim, Ives, Angela, Lee, Yeh Chen, Brand, Alison, Mellon, Anne, Bilic, Sanela, Black, Isobel, Jeffares, Stephanie and Friedlander, Michael (2022). Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancer. International Journal of Gynecological Cancer, 32 (4) 002999, 560-565. doi: 10.1136/ijgc-2021-002999 |
|
2022 Journal Article Patient experiences of conservative treatment for early stage endometrial cancer and endometrial hyperplasia with atypia using levonorgestrel intrauterine device: a qualitative studyO'Hara, Montana, Janda, Monika, McCarthy, Alexandra L., Nicklin, James, Walker, Graeme and Obermair, Andreas (2022). Patient experiences of conservative treatment for early stage endometrial cancer and endometrial hyperplasia with atypia using levonorgestrel intrauterine device: a qualitative study. Gynecologic Oncology Reports, 39 100914, 100914. doi: 10.1016/j.gore.2021.100914 |
|
2022 Journal Article Evaluating patient-reported symptoms and late adverse effects following completion of first-line chemotherapy for ovarian cancer using the MOST (Measure of Ovarian Symptoms and Treatment concerns)Beesley, Vanessa L., Ross, Tanya L., King, Madeleine T., Campbell, Rachel, Nagle, Christina M., Obermair, Andreas, Grant, Peter, DeFazio, Anna, Webb, Penelope M. and Friedlander, Michael L. (2022). Evaluating patient-reported symptoms and late adverse effects following completion of first-line chemotherapy for ovarian cancer using the MOST (Measure of Ovarian Symptoms and Treatment concerns). Gynecologic Oncology, 164 (2), 437-445. doi: 10.1016/j.ygyno.2021.12.006 |
|
2022 Journal Article Post-recurrence survival in patients with cervical cancerCibula, David, Dostálek, Lukáš, Jarkovsky, Jiri, Mom, Constantijne H., Lopez, Aldo, Falconer, Henrik, Scambia, Giovanni, Ayhan, Ali, Kim, Sarah H., Isla Ortiz, David, Klat, Jaroslav, Obermair, Andreas, Di Martino, Giampaolo, Pareja, Rene, Manchanda, Ranjit, Kosťun, Jan, dos Reis, Ricardo, Meydanli, Mehmet Mutlu, Odetto, Diego, Laky, Rene, Zapardiel, Ignacio, Weinberger, Vit, Benešová, Klára, Borčinová, Martina, Cardenas, Fernando, Wallin, Emelie, Pedone Anchora, Luigi, Akilli, Huseyin, Abu-Rustum, Nadeem R. ... van Lonkhuijzen, Luc R.C.W. (2022). Post-recurrence survival in patients with cervical cancer. Gynecologic Oncology, 164 (2), 362-369. doi: 10.1016/j.ygyno.2021.12.018 |
|
2021 Journal Article Fertility-sparing management of early-stage endometrial cancer in reproductive age women: current treatment outcomes and future directionsJanda, Monika and Obermair, Andreas (2021). Fertility-sparing management of early-stage endometrial cancer in reproductive age women: current treatment outcomes and future directions. International Journal of Gynecological Cancer, 31 (12) ijgc-2021-003192, 1506-1507. doi: 10.1136/ijgc-2021-003192 |
|
2021 Journal Article A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer – ENDO-3: ANZGOG trial 1911/2020Obermair, Andreas, Nicklin, Jim, Gebski, Val, Hayes, Sandra C., Graves, Nicholas, Mileshkin, Linda, Lin, Ming Yin, Beale, Phillip, Baxter, Eva, Robledo, Kristy, Salomon, Carlos, Hanna, George B. and Janda, Monika (2021). A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer – ENDO-3: ANZGOG trial 1911/2020. International Journal of Gynecologic Cancer, 31 (12) ijgc-2021-003029, 1595-1601. doi: 10.1136/ijgc-2021-003029 |
|
2021 Journal Article The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancerCibula, David, Dostálek, Lukáš, Jarkovsky, Jiri, Mom, Constantijne H., Lopez, Aldo, Falconer, Henrik, Fagotti, Anna, Ayhan, Ali, Kim, Sarah H., Isla Ortiz, David, Klat, Jaroslav, Obermair, Andreas, Landoni, Fabio, Rodriguez, Juliana, Manchanda, Ranjit, Kosťun, Jan, dos Reis, Ricardo, Meydanli, Mehmet M., Odetto, Diego, Laky, Rene, Zapardiel, Ignacio, Weinberger, Vit, Benešová, Klára, Borčinová, Martina, Pari, Darwin, Salehi, Sahar, Bizzarri, Nicolò, Akilli, Huseyin, Abu-Rustum, Nadeem R. ... van Lonkhuijzen, Luc R.C.W. (2021). The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer. European Journal of Cancer, 158, 111-122. doi: 10.1016/j.ejca.2021.09.008 |
